Stereotactic Radiotherapy for Cerebral Metastases with Recent Hemorrhagic Signal

Clinical trial NCT03696680 · RECRUITING

Trial details

NCT number: NCT03696680
Sponsor: Centre Francois Baclesse
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hemorrhagic Brain Metastases

Start date: 2019-01-16
Primary completion: 2027-06-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.